EP Patent

EP3285771A4 — Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa

Assigned to Sumitomo Pharma America Inc · Expires 2018-12-05 · 7y expired

What this patent protects

Patent listed against apomorphine-hydrochloride.

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3285771A4
Jurisdiction: EP
Classification: —
Expires: 2018-12-05
Drug substance claim: No
Drug product claim: No
Assignee: Sumitomo Pharma America Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.